| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 936 | 2018 |
| MRI characteristics of neuromyelitis optica spectrum disorder: an international update HJ Kim, F Paul, MA Lana-Peixoto, S Tenembaum, N Asgari, J Palace, ... Neurology 84 (11), 1165-1173, 2015 | 599 | 2015 |
| Natural history of multiple sclerosis symptoms I Kister, TE Bacon, E Chamot, AR Salter, GR Cutter, JT Kalina, J Herbert International journal of MS care 15 (3), 146-156, 2013 | 504 | 2013 |
| Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ... The Lancet Neurology 19 (4), 307-316, 2020 | 287 | 2020 |
| Disability in multiple sclerosis: a reference for patients and clinicians I Kister, E Chamot, AR Salter, GR Cutter, TE Bacon, J Herbert Neurology 80 (11), 1018-1024, 2013 | 233 | 2013 |
| Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ... Neurology 89 (11), 1107-1116, 2017 | 228 | 2017 |
| Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing LZ Ryerson, J Foley, I Chang, I Kister, G Cutter, RR Metzger, JD Goldberg, ... Neurology 93 (15), e1452-e1462, 2019 | 168 | 2019 |
| Neurologic manifestations of localized scleroderma: a case report and literature review I Kister, M Inglese, RM Laxer, J Herbert Neurology 71 (19), 1538-1545, 2008 | 163 | 2008 |
| COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center E Parrotta, I Kister, L Charvet, C Sammarco, V Saha, RE Charlson, ... Neurology: Neuroimmunology & Neuroinflammation 7 (5), e835, 2020 | 158 | 2020 |
| Extended interval dosing of natalizumab in multiple sclerosis LZ Ryerson, TC Frohman, J Foley, I Kister, B Weinstock-Guttman, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (8), 885-889, 2016 | 154 | 2016 |
| Rapid disease course in African Americans with multiple sclerosis I Kister, E Chamot, JH Bacon, PM Niewczyk, RA De Guzman, B Apatoff, ... Neurology 75 (3), 217-223, 2010 | 154 | 2010 |
| Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course I Kister, AB Caminero, TS Monteith, A Soliman, TE Bacon, JH Bacon, ... The Journal of headache and pain 11 (5), 417-425, 2010 | 136 | 2010 |
| Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study I Kister, T Spelman, R Alroughani, J Lechner-Scott, P Duquette, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (10), 1133-1137, 2016 | 104 | 2016 |
| Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans RE Ventura, AO Antezana, T Bacon, I Kister Multiple Sclerosis Journal 23 (11), 1554-1557, 2017 | 101 | 2017 |
| Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy I Kister, S Gulati, C Boz, R Bergamaschi, G Piccolo, J Oger, ML Swerdlow Archives of neurology 63 (6), 851-856, 2006 | 100 | 2006 |
| Ultrahigh-field MR (7 T) imaging of brain lesions in neuromyelitis optica I Kister, J Herbert, Y Zhou, Y Ge Multiple Sclerosis International 2013, 2013 | 94 | 2013 |
| Treatment of MOG antibody associated disorders: results of an international survey DH Whittam, V Karthikeayan, E Gibbons, R Kneen, S Chandratre, ... Journal of neurology 267, 3565-3577, 2020 | 85 | 2020 |
| Mortality in neuromyelitis optica is strongly associated with African ancestry MA Mealy, RA Kessler, Z Rimler, A Reid, L Totonis, G Cutter, I Kister, ... Neurology: Neuroimmunology & Neuroinflammation 5 (4), e468, 2018 | 81 | 2018 |
| Iron and non-iron-related characteristics of multiple sclerosis and neuromyelitis optica lesions at 7T MRI S Chawla, I Kister, J Wuerfel, JC Brisset, S Liu, T Sinnecker, P Dusek, ... American Journal of Neuroradiology 37 (7), 1223-1230, 2016 | 77 | 2016 |
| Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry RJ Fox, TE Bacon, E Chamot, AR Salter, GR Cutter, JT Kalina, I Kister Neurodegener Dis Manag 5 (6 Suppl), 3-10, 2015 | 76 | 2015 |
Yulin GeProfessor or Radiology, New York University School of MedicineVerified email at nyumc.org
